On Tuesday, June 10, 2025, the Convergence Project held a virtual event, “From Barriers to Breakthroughs: Funding, Resources, and Support to Improve Clinical Trial Access and Innovation,” hosted by FasterCures in partnership with The Multi-Regional Clinical Trials Center at Brigham and Women’s Hospital and Harvard (The MRCT Center).
The webinar opened with a discussion about the current imperatives to advance representation in clinical trials, and a brief overview of the Convergence Project, including the eight domains (public awareness and communication, community engagement and investment, site enablement, workforce, trial participation and access, comprehensive data, funding resources and support, accountability) outlined in Toward A National Action Plan for Achieving Diversity In Clinical Trials. Panelists explored the systemic barriers that limit access, from financial burdens on patients and caregivers to gaps in community trust and investment.
More than 140 virtual attendees joined to hear discussions featuring leaders from across the clinical trial ecosystem, including patient advocacy and community-serving organizations, foundations, venture capital, digital health, and pharmaceutical companies.
Review this summary for more about the discussion topics and key takeaways.
The 26th annual Milken Institute Global Conference convened the best minds in the world to tackle its most urgent challenges and realize its most exciting opportunities. Throughout the four-day event, our health teams curated nearly three...
Clinical trial networks, as evidenced during the COVID-19 pandemic, really are “national critical infrastructure.” The pandemic revealed prominent gaps and stark differences in health outcomes across various populations. A community-based...
While the response to the COVID-19 pandemic has exposed many of the fault lines in the biomedical innovation ecosystem that have slowed progress for decades, we have also shown ourselves capable of innovating in ways we perhaps did not...
FasterCures wants to ensure that the lessons of the COVID-19 crisis are not lost once the current urgency subsides — not only for combating future infectious diseases, but for conducting every other aspect of biomedical innovation...
The United States biomedical research and innovation enterprise has long been a source of global leadership, scientific breakthroughs, and lifesaving treatments. Decades of investments in research and development have positioned the US as...
The United States biomedical research and innovation enterprise has long been a source of global leadership, scientific breakthroughs, and lifesaving treatments.
FasterCures is launching Access Point: Trends in Trial Transformation, a quarterly horizon scan examining how emerging trends, organizations, and initiatives are transforming clinical trial access and efficiency.
In This Newsletter Program Updates Events and Convenings Recap Recent Publications Policy Updates FasterCures in the Community Upcoming Events Program Updates FasterCures Awarded FDA Funding to Advance Patient Engagement in Medtech...
Esther Krofah is the executive vice president of Milken Institute Health, leading FasterCures, Public Health, the Future of Aging, and Feeding Change. She has extensive experience managing efforts to unite diverse stakeholders to solve critical issues and achieve shared goals that improve patients’ lives.
In 2022, FasterCures published a report titled The Current Landscape of the Science of Patient Input, which examined the progress of patient engagement (PE) in biomedical research and identified ways to overcome ongoing challenges. Building...
June 24, 2024 (Washington, DC)— Clinical trials can provide the possibility to obtain novel treatments for conditions and diseases that are not yet commercially available. Yet, these lifesaving treatments are often difficult or impossible...
Paul Guequierre is the director of strategic communications. In this role, he works to increase the profile of Milken Institute in the media, raise the visibility of issues important to the organization and its stakeholders, and expand the Institute's digital presence.